Paper35525908
Cardiac Organoids: A 3D Technology for Modeling Heart Development and Disease.
Zhu L and 3 others. Stem Cell Rev Rep, 2022. Cited by 32 papers, by iCite.
Cite this record
ConductScience Library. Cardiac Organoids: A 3D Technology for Modeling Heart Development and Disease. Papers, record 35525908. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35525908
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Organoids | Major topic |
| Induced Pluripotent Stem Cells | Major topic |
| Humans | |
| Organogenesis | |
| Regenerative Medicine | |
| Technology |
Source PubMed
References91
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34208210 | Tunable Human Myocardium Derived Decellularized Extracellular Matrix for 3D Bioprinting and Cardiac Tissue Engineering. | Gels | 2021 | https://conductscience.org/library/papers/34208210 | PubMed |
| 2 | 28167635 | Defined Engineered Human Myocardium With Advanced Maturation for Applications in Heart Failure Modeling and Repair. | Circulation | 2017 | https://conductscience.org/library/papers/28167635 | PubMed |
| 3 | 28931002 | Enhanced proofreading governs CRISPR-Cas9 targeting accuracy. | Nature | 2017 | https://conductscience.org/library/papers/28931002 | PubMed |
| 4 | 27765793 | A Precision Medicine Approach to the Rescue of Function on Malignant Calmodulinopathic Long-QT Syndrome. | Circ Res | 2017 | https://conductscience.org/library/papers/27765793 | PubMed |
| 5 | 29233823 | Large Cardiac Muscle Patches Engineered From Human Induced-Pluripotent Stem Cell-Derived Cardiac Cells Improve Recovery From Myocardial Infarction in Swine. | Circulation | 2018 | https://conductscience.org/library/papers/29233823 | PubMed |
| 6 | 27642787 | iPSC-derived cardiomyocytes reveal abnormal TGF-β signalling in left ventricular non-compaction cardiomyopathy. | Nat Cell Biol | 2016 | https://conductscience.org/library/papers/27642787 | PubMed |
| 7 | 31385592 | Engineered Cardiac Tissues Generated in the Biowire II: A Platform for Human-Based Drug Discovery. | Toxicol Sci | 2019 | https://conductscience.org/library/papers/31385592 | PubMed |
| 8 | 30623132 | Novel Adult-Onset Systolic Cardiomyopathy Due to MYH7 E848G Mutation in Patient-Derived Induced Pluripotent Stem Cells. | JACC Basic Transl Sci | 2018 | https://conductscience.org/library/papers/30623132 | PubMed |
| 9 | 9521325 | Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. | Nature | 1998 | https://conductscience.org/library/papers/9521325 | PubMed |
| 10 | 26735016 | High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects. | Nature | 2016 | https://conductscience.org/library/papers/26735016 | PubMed |
| 11 | 29525646 | Gene Editing and Gene-Based Therapeutics for Cardiomyopathies. | Heart Fail Clin | 2018 | https://conductscience.org/library/papers/29525646 | PubMed |
| 12 | 28174241 | Development of a human cardiac organoid injury model reveals innate regenerative potential. | Development | 2017 | https://conductscience.org/library/papers/28174241 | PubMed |
| 13 | 17971785 | Identifying genetic risk factors for serious adverse drug reactions: current progress and challenges. | Nat Rev Drug Discov | 2007 | https://conductscience.org/library/papers/17971785 | PubMed |
| 14 | 28765558 | Cardiac spheroids as promising in vitro models to study the human heart microenvironment. | Sci Rep | 2017 | https://conductscience.org/library/papers/28765558 | PubMed |
| 15 | 32464269 | Decellularized tissues as platforms for in vitro modeling of healthy and diseased tissues. | Acta Biomater | 2020 | https://conductscience.org/library/papers/32464269 | PubMed |
| 16 | 26911908 | Organoids as an in vitro model of human development and disease. | Nat Cell Biol | 2016 | https://conductscience.org/library/papers/26911908 | PubMed |
| 17 | 16339494 | Engineering myocardial tissue. | Circ Res | 2005 | https://conductscience.org/library/papers/16339494 | PubMed |
| 18 | 26433566 | Development of a three-dimensional pre-vascularized scaffold-free contractile cardiac patch for treating heart disease. | J Heart Lung Transplant | 2016 | https://conductscience.org/library/papers/26433566 | PubMed |
| 19 | 26503464 | Bioengineering Human Myocardium on Native Extracellular Matrix. | Circ Res | 2016 | https://conductscience.org/library/papers/26503464 | PubMed |
| 20 | 30710266 | Measurement of Contractility and Calcium Release in Cardiac Spheroids. | Methods Mol Biol | 2019 | https://conductscience.org/library/papers/30710266 | PubMed |
Cited by24
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 32 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42882452 | Emerging Technologies in Cardiovascular Disease Modeling: Bridging Basic Science and Clinical Translation. | Cells | 2026 | https://conductscience.org/library/papers/42882452 | PubMed |
| 42637927 | The cardiac protective human circular RNA circKLHL20_009 sponges miR-31-5p to ameliorate myocardial hypertrophy and fibrosis through suppressing β-catenin signaling. | Acta Pharmacol Sin | 2026 | https://conductscience.org/library/papers/42637927 | PubMed |
| 42579795 | From aging biology to cardiac biotechnology: emerging platforms for modeling cardiac aging. | JCI Insight | 2026 | https://conductscience.org/library/papers/42579795 | PubMed |
| 42306928 | Advances in Biomaterial-Based Cardiac Organoids Engineering for Modeling Development and Congenital Heart Defects. | ACS Appl Bio Mater | 2026 | https://conductscience.org/library/papers/42306928 | PubMed |
| 42277205 | S1UTRSP5, a short restructured RNA from SLIT1 3'UTR, mitigates mouse cardiac remodeling via enhancing SlRT1 activity. | Acta Pharmacol Sin | 2026 | https://conductscience.org/library/papers/42277205 | PubMed |
| 41677066 | Patient-Derived 3D Bioprinted Cardiac Organoid Constructs Reveal Key Pathological Features of Duchenne Muscular Dystrophy. | Adv Healthc Mater | 2026 | https://conductscience.org/library/papers/41677066 | PubMed |
| 41618376 | Advanced imaging strategies in cardiac organoids: bridging the gap between structural complexity and functional analysis. | Cardiovasc Diabetol | 2026 | https://conductscience.org/library/papers/41618376 | PubMed |
| 41556511 | Unraveling the Genetic Mysteries of Müllerian Anomalies: Research Approaches and Clinical Significance. | Clin Genet | 2026 | https://conductscience.org/library/papers/41556511 | PubMed |
| 41373741 | Integrating Bioprinting and Increased Throughput: Next-Generation Models for Cardiac Research. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41373741 | PubMed |
| 41261979 | In vitro approaches to mimic cardiac mechanical load dynamics for enhancing maturation and disease modelling. | Cardiovasc Res | 2025 | https://conductscience.org/library/papers/41261979 | PubMed |
| 40721504 | circSP199a, a circularized RNA sponge targeting miR-199a-5p and -3p, mitigates mouse cardiac hypertrophy and fibrosis. | Acta Pharmacol Sin | 2026 | https://conductscience.org/library/papers/40721504 | PubMed |
| 40321594 | Organoid-Guided Precision Medicine: From Bench to Bedside. | MedComm (2020) | 2025 | https://conductscience.org/library/papers/40321594 | PubMed |
| 39872935 | Model construction and clinical therapeutic potential of engineered cardiac organoids for cardiovascular diseases. | Biomater Transl | 2024 | https://conductscience.org/library/papers/39872935 | PubMed |
| 39802826 | Revolutionizing cardiovascular research: Human organoids as a Beacon of hope for understanding and treating cardiovascular diseases. | Mater Today Bio | 2025 | https://conductscience.org/library/papers/39802826 | PubMed |
| 39707562 | Small extracellular vesicles derived from umbilical cord mesenchymal stem cells alleviate radiation-induced cardiac organoid injury. | Stem Cell Res Ther | 2024 | https://conductscience.org/library/papers/39707562 | PubMed |
| 39126669 | Progress in the Application of Organoids-On-A-Chip in Diseases. | Organogenesis | 2024 | https://conductscience.org/library/papers/39126669 | PubMed |
| 38543122 | Differentiation of Pluripotent Stem Cells for Disease Modeling: Learning from Heart Development. | Pharmaceuticals (Basel) | 2024 | https://conductscience.org/library/papers/38543122 | PubMed |
| 38334642 | Advances in the Generation of Constructed Cardiac Tissue Derived from Induced Pluripotent Stem Cells for Disease Modeling and Therapeutic Discovery. | Cells | 2024 | https://conductscience.org/library/papers/38334642 | PubMed |
| 38110859 | The benign nature and rare occurrence of cardiac myxoma as a possible consequence of the limited cardiac proliferative/ regenerative potential: a systematic review. | BMC Cancer | 2023 | https://conductscience.org/library/papers/38110859 | PubMed |
| 37958655 | A Strainer-Based Platform for the Collection and Immunolabeling of Porcine Epidemic Diarrhea Virus-Infected Porcine Intestinal Organoid. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37958655 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35525908
GET https://conductscience.org/api/papers/v1/35525908/references?page=2